Literature DB >> 17038738

ABC of obesity. Management: part II--drugs.

Mike Lean1, Nick Finer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17038738      PMCID： PMC1602026          DOI： 10.1136/bmj.333.7572.794

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

Review 1.  Safety of obesity drugs.

Authors:  Frank L Greenway; Mary K Caruso
Journal:  Expert Opin Drug Saf       Date:  2005-11       Impact factor: 4.250

Review 2.  Novel therapeutic targets for appetite regulation.

Authors:  Caroline J Small; James R Parkinson; Stephen R Bloom
Journal:  Curr Opin Investig Drugs       Date:  2005-04

3.  Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight.

Authors:  Michael Rosenbaum; Rochelle Goldsmith; Daniel Bloomfield; Anthony Magnano; Louis Weimer; Steven Heymsfield; Dympna Gallagher; Laurel Mayer; Ellen Murphy; Rudolph L Leibel
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

Review 4.  The endocannabinoid system and the treatment of obesity.

Authors:  Uberto Pagotto; Valentina Vicennati; Renato Pasquali
Journal:  Ann Med       Date:  2005       Impact factor: 4.709

5.  A health economic model to assess the long-term effects and cost-effectiveness of orlistat in obese type 2 diabetic patients.

Authors:  Mark Lamotte; Lieven Annemans; Aurelia Lefever; Myriam Nechelput; Johan Masure
Journal:  Diabetes Care       Date:  2002-02       Impact factor: 19.112

Review 6.  Orlistat: a review of its use in the management of patients with obesity.

Authors:  Monique P Curran; Lesley J Scott
Journal:  Drugs       Date:  2004       Impact factor: 9.546

7.  Predictive value of early weight loss in obesity management with orlistat: an evidence-based assessment of prescribing guidelines.

Authors:  A Rissanen; M Lean; S Rössner; K R Segal; L Sjöström
Journal:  Int J Obes Relat Metab Disord       Date:  2003-01
  7 in total
  6 in total

1.  Changes in body weight and blood pressure: paradoxical outcome events in overweight and obese subjects with cardiovascular disease.

Authors:  R V Seimon; D Espinoza; L Ivers; V Gebski; N Finer; U F Legler; A M Sharma; W P T James; W Coutinho; I D Caterson
Journal:  Int J Obes (Lond)       Date:  2014-01-10       Impact factor: 5.095

2.  Impaired intestinal afferent nerve satiety signalling and vagal afferent excitability in diet induced obesity in the mouse.

Authors:  Donna M Daly; Sung Jin Park; William C Valinsky; Michael J Beyak
Journal:  J Physiol       Date:  2011-03-21       Impact factor: 5.182

3.  Changes in body weight and pulse: outcome events in overweight and obese subjects with cardiovascular disease in the SCOUT trial.

Authors:  R V Seimon; D Espinoza; N Finer; W P T James; U F Legler; W Coutinho; A M Sharma; L Van Gaal; A P Maggioni; A Sweeting; C Torp-Pedersen; V Gebski; I D Caterson
Journal:  Int J Obes (Lond)       Date:  2014-12-18       Impact factor: 5.095

4.  Feasibility and indicative results from a 12-month low-energy liquid diet treatment and maintenance programme for severe obesity.

Authors:  Michael Lean; Naomi Brosnahan; Philip McLoone; Louise McCombie; Anna Bell Higgs; Hazel Ross; Mhairi Mackenzie; Eleanor Grieve; Nick Finer; John Reckless; David Haslam; Billy Sloan; David Morrison
Journal:  Br J Gen Pract       Date:  2013-02       Impact factor: 5.386

5.  The effects of moderate alterations in adrenergic activity on acute appetite regulation in obese women: A randomised crossover trial.

Authors:  Fotini Tsofliou; Yannis P Pitsiladis; Jose Lara; Marios Hadjicharalambous; Ian A Macdonald; Mike A Wallace; Mike E J Lean
Journal:  Nutr Health       Date:  2020-07-30

Review 6.  Surgery for weight loss in adults.

Authors:  Jill L Colquitt; Karen Pickett; Emma Loveman; Geoff K Frampton
Journal:  Cochrane Database Syst Rev       Date:  2014-08-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.